Publications (67) Publications de ELENA SUÁREZ GONZÁLEZ

2024

  1. Eduardo Areitio Cebrecos: en el recuerdo coord.

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 121, Núm. 2, pp. 99-100

2023

  1. Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions

    Pharmaceutics, Vol. 15, Núm. 2

  2. Non-Adherence in Adult Male Patients with Community-Acquired Pneumonia: Relative Forgiveness of Amoxicillin versus Respiratory Fluoroquinolones

    Antibiotics, Vol. 12, Núm. 5

  3. Transformación del modelo de Atención Médica en la era digital

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 120, Núm. 4, pp. 167-168

2022

  1. Application of physiologically based absorption and pharmacokinetic modeling in the development process of oral modified release generic products

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, Vol. 176, pp. 87-94

  2. Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability

    Antibiotics, Vol. 11, Núm. 5

  3. Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

    Journal of Fungi, Vol. 8, Núm. 7

2021

  1. Application of a dual mechanistic approach to support bilastine dose selection for older adults

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 10, Núm. 9, pp. 1006-1017

2020

  1. Nueva sección en la página web de la Academia de Ciencias Médicas de Bilbao: información sobre el nuevo coronavirus SARS-CoV-2

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 117, Núm. 2, pp. 71-72

2016

  1. In vitro pharmacodynamic modelling of anidulafungin against Candida spp.

    International Journal of Antimicrobial Agents, Vol. 47, Núm. 3, pp. 178-183

2015

  1. Impact of poor compliance with levofloxacin and moxifloxacin on respiratory tract infection antimicrobial efficacy: A pharmacokinetic/pharmacodynamic simulation study

    International Journal of Antimicrobial Agents, Vol. 45, Núm. 1, pp. 79-83

  2. Quantitative determination of fentanyl in newborn pig plasma and cerebrospinal fluid samples by HPLC-MS/MS

    Drug Testing and Analysis, Vol. 7, Núm. 9, pp. 804-811

2014

  1. Evaluation of fentanyl disposition and effects in newborn piglets as an experimental model for human neonates

    PLoS ONE, Vol. 9, Núm. 3

2013

  1. A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach

    Pediatric Drugs, Vol. 15, Núm. 3, pp. 247-257

  2. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: Pharmacokinetic considerations and patient pathophysiology

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 51, Núm. 7, pp. 606-614

  3. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction

    European Journal of Clinical Pharmacology, Vol. 69, Núm. 1, pp. 65-74

2011

  1. Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation

    European Journal of Clinical Pharmacology, Vol. 67, Núm. 7, pp. 671-679

2010

  1. Responsabilidades éticas y cambio editorial en Gaceta Médica de Bilbao

    Gaceta Medica de Bilbao

  2. Simulation of sirolimus exposures and population variability immediately post renal transplantation: Importance of the patient's CYP3A5 genotype in tailoring treatment

    Biopharmaceutics and Drug Disposition, Vol. 31, Núm. 2-3, pp. 129-137

2009

  1. Population pharmacokinetics of recombinant factor VIII:C (ReFacto®) in adult HIV-negative and HIV-positive haemophilia patients

    European Journal of Clinical Pharmacology, Vol. 65, Núm. 11, pp. 1121-1130